Skip to content
sellWeak cluster of 410b5-1 plan

Jack W Callicutt sold $197k of GALT

Chief Financial Officer at GALECTIN THERAPEUTICS INC. 32,439 shares at an average of $6.06, traded Nov 3, 2025, filed Nov 5, 2025.

Warning score
34
Value
$197k
32,439 shares
Holdings after
7,614
-364% from before
From 52-week low
+614%
low $0.84, close $6.00
From 52-week high
0%
high $6.00, as of Nov 3, 2025

Score components

  • Role
    CFO
    +22
  • Trade size
    $197k at market
    +12
  • Share of holdings sold
    Sold 100% of holdings
    +20
  • Cluster
    4 insiders selling within 14 days
    +15
  • Exercise and sell
    Shares came from an option exercise in the same filing
    -15
  • 10b5-1 plan
    Pre-scheduled under a 10b5-1 plan
    -20

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m +2.0%, 3m -47.4%, 6m -60.0%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

GALTOct 9, 2026 · close 3.94
Since filing Nov 5, 2025: -30.0%SPY +16.1% · excess -46.1%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001133416-25-000043, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Nov 3, 2025MOption exercise
Common Stock10b5-1
+1,300$1.98$2,5748,914Nov 5, 2025
Nov 3, 2025SOpen-market sale
Common Stock10b5-1
-1,300$6.01$7,8137,614Nov 5, 2025
Nov 3, 2025MOption exercise
Common Stock10b5-1
+1,260$1.11$1,3998,874Nov 5, 2025
Nov 3, 2025SOpen-market sale
Common Stock10b5-1
-1,260$6.01$7,5737,614Nov 5, 2025
Nov 3, 2025MOption exercise
Common Stock10b5-1
+1,250$1.72$2,1508,864Nov 5, 2025
Nov 3, 2025SOpen-market sale
Commno stock10b5-1
-1,250$6.01$7,5137,614Nov 5, 2025
Nov 4, 2025MOption exercise
Common stock10b5-1
+8,914$1.98$18k16,528Nov 5, 2025
Nov 4, 2025SOpen-market sale
Common stock10b5-1
-8,914$6.07$54k7,614Nov 5, 2025
Nov 4, 2025MOption exercise
Common stock10b5-1
+8,974$1.11$9,96116,588Nov 5, 2025
Nov 4, 2025SOpen-market sale
Common stock10b5-1
-8,974$6.07$54k7,614Nov 5, 2025
Nov 4, 2025MOption exercise
Common stock10b5-1
+10,741$1.72$18k18,355Nov 5, 2025
Nov 4, 2025SOpen-market sale
Common stock10b5-1
-10,741$6.07$65k7,614Nov 5, 2025
Nov 3, 2025MOption exercise
Stock option (right to buy)derivative10b5-1
-1,300$0.00$048,700Nov 5, 2025
Nov 3, 2025MOption exercise
Stock option (right to buy)derivative10b5-1
-1,260$0.00$048,740Nov 5, 2025
Nov 3, 2025MOption exercise
Stock option (right to buy)derivative10b5-1
-1,250$0.00$063,750Nov 5, 2025
Nov 4, 2025MOption exercise
Stock option (right to buy)derivative10b5-1
-8,914$0.00$039,786Nov 5, 2025
Nov 4, 2025MOption exercise
Stock option (right to buy)derivative10b5-1
-8,974$0.00$039,766Nov 5, 2025
Nov 4, 2025MOption exercise
Stock option (right to buy)derivative10b5-1
-10,741$0.00$053,009Nov 5, 2025

Related signals

Other insiders at GALECTIN THERAPEUTICS INC and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
9Weak
GALTsell10b5-1
GALECTIN THERAPEUTICS INC
Khurram Jamil
Chief Medical Officer
$83k
16,250 shares
-100%
21Weak
GALTsell 210b5-1
GALECTIN THERAPEUTICS INC
Khurram Jamil
Chief Medical Officer
$262k
52,037 shares
-2555%
19Weak
GALTsell 210b5-1
GALECTIN THERAPEUTICS INC
Harold H. Shlevin
director
$151k
30,000 shares
-211%
8Weak
GALTsell 210b5-1
GALECTIN THERAPEUTICS INC
Khurram Jamil
Chief Medical Officer
$24k
7,557 shares
-100%
0Weak
GALTsell10b5-1
GALECTIN THERAPEUTICS INC
Khurram Jamil
Chief Medical Officer
$1,761
568 shares
-100%
23Weak
GALTbuy
GALECTIN THERAPEUTICS INC
Kary Eldred
director
$810
300 shares
+0%
35Weak
GALTsell 310b5-1
GALECTIN THERAPEUTICS INC
Jack W Callicutt
Chief Financial Officer
$233k
60,000 shares
-89%
28Weak
GALTsell 310b5-1
GALECTIN THERAPEUTICS INC
Khurram Jamil
Chief Medical Officer
$232k
60,000 shares
-100%
19Weak
GALTsell 310b5-1
GALECTIN THERAPEUTICS INC
Joel Lewis
President and CEO
$321k
84,000 shares
-9%
21Weak
GALTsell 410b5-1
GALECTIN THERAPEUTICS INC
Khurram Jamil
Chief Medical Officer
$33k
8,125 shares
-100%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Jack W Callicutt sold $197k of GALT | InsiderTell